Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 -0.28 (-0.72%) Market Cap: 5.66 Bil Enterprise Value: 4.94 Bil PE Ratio: 0 PB Ratio: 19.11 GF Score: 74/100

Ionis Pharmaceuticals Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 10, 2020 / 05:20PM GMT
Release Date Price: $51.52 (-3.07%)
Operator

Welcome to the Wells Fargo Healthcare Conference. Before we start, please note that Wells Fargo Securities events are by invitation only. Members of the press or media are not permitted to join. If you are a member of the press or media, please disconnect at this time. Also please be advised that today's conference is being recorded. Thank you.

James William Birchenough
Wells Fargo Securities, LLC, Research Division - MD and Senior Biotechnology Analyst

Great. Well, thanks, everyone, for joining our Global Healthcare Conference here at Wells Fargo. We're sorry about the late start, but worth the wait.

We've got Ionis Pharmaceuticals and their CEO, Dr. Brett Monia, on the line. He's joined by Beth Hougen, their CFO. And we have a bit of a shortened time frame. So we're going to do a little bit of a lightning round and maybe focus on the most relevant parts.

Questions & Answers

James William Birchenough
Wells Fargo Securities, LLC, Research Division - MD and Senior Biotechnology Analyst

But, Brett

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot